Clinical trial
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea
NCT00219401 · Papua New Guinea Institute of Medical Research, Other · Completed
Key facts
| NCT number | NCT00219401 |
|---|---|
| Title | Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea |
| Official title | Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea |
| Lead sponsor | Papua New Guinea Institute of Medical Research, Other |
| Collaborators | The University of Western Australia |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pneumonia, Meningitis, Otitis Media |
| Intervention type | Biological |
| Interventions | Pneumococcal 7 valent conjugate vaccine (Prevenar®) |
| Enrollment | 318 |
| Start date | May 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 12, 2011 |
| Countries | Papua New Guinea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: